Findings from a new study indicate that compared with children who were not exposed to the drug, children with in utero exposure to sodium valproate have lower scores on national tests at age 7 years.
Ionis to Advance ION582 in Phase 3 Studies of Angelman Syndrome Following Positive Open-Label Data
Episode 116: Understanding Vorasidenib's Therapeutic Benefit on Neurocognition, Seizure Control in Diffuse Gliomas
This Week on NeurologyLive® — July 22, 2024
Special Episode: FDA Approves Diazepam Buccal Film for Pediatric Seizures
NeurologyLive® Friday 5 — July 19, 2024
Updates in Therapeutic Development: Clinical Trial Readouts to Watch in the Second Half of 2024